Volume 17, Number 9—September 2011
Dispatch
Multidrug-Resistant Acinetobacter baumannii in Veterinary Clinics, Germany
Sabrina Zordan
, Ellen Prenger-Berninghoff, Reinhard Weiss, Tanny van der Reijden, Peterhans van den Broek, Georg Baljer, and Lenie Dijkshoorn
, Ellen Prenger-Berninghoff, Reinhard Weiss, Tanny van der Reijden, Peterhans van den Broek, Georg Baljer, and Lenie DijkshoornTable
Resistance profiles of 56 animal Acinetobacter spp. isolates for 19 antimicrobial agents, obtained by CLSI broth microdilution test *
| Profile; no. isolates | Tested antimicrobial agents |
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oxa | Pen | Ctn | Ery | Cli | Chl | Cst | Cvf | Amp | Amc | Tet | Enr | Orb | Dif | Kan | Sxt | Gen | Ipm | Amk | |
| 1; 1 | R | R | R | R | R | R | R | R | R | R | R | R | I | R | R | R | R | R | S |
| 2; 1 | R | R | R | R | R | R | R | R | R | R | I | R | R | R | R | R | R | S | R |
| 3; 28 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | S | S |
| 4; 2 | R | R | R | R | R | R | R | I | R | R | R | R | R | R | R | R | R | S | S |
| 5; 2 | R | R | R | R | R | R | R | R | R | I | R | R | R | R | R | R | R | S | S |
| 6; 1 | R | R | R | R | R | R | R | R | R | R | I | R | R | R | R | R | R | S | S |
| 7; 1 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | S | R | R | S | S |
| 8; 1 | R | R | R | R | R | R | R | R | R | R | I | R | R | R | R | R | S | S | S |
| 9; 3 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | S | S | S | S |
| 10; 1 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | I | S | S | S | S |
| 11; 1 | R | R | R | R | R | R | R | R | R | R | I | R | R | R | R | S | S | S | S |
| 12; 1 | R | R | R | R | R | R | S | R | R | R | R | R | R | R | R | S | S | S | S |
| 13; 1 | R | R | R | R | R | R | R | R | R | I | R | S | S | S | R | R | R | S | S |
| 14; 3 | R | R | R | R | R | R | R | R | I | I | R | R | R | R | S | S | S | S | S |
| 15; 1 | R | R | R | R | R | R | R | R | I | I | R | R | R | R | S | S | S | S | S |
| 16; 2 | R | R | R | R | R | R | R | R | I | I | S | S | S | S | S | S | S | S | S |
| 17; 1 | R | R | R | R | R | R | R | R | I | S | S | S | S | S | S | S | S | S | S |
| 18; 1 | R | R | R | R | R | R | R | I | I | S | S | S | S | S | S | S | S | S | S |
| 19; 1 | R | R | R | R | R | R | R | R | S | S | S | S | S | S | S | S | S | S | S |
| 20; 1 | R | R | R | R | R | R | R | I | S | S | S | S | S | S | S | S | S | S | S |
| 21; 1 | R | R | R | R | R | R | S | R | S | S | S | S | S | S | S | S | S | S | S |
| 22; 1 | R | R | R | R | R | R | S | I | S | S | S | S | S | S | S | S | S | S | S |
*CLSI guidelines M31-A2 (9). CLSI, Clinical Laboratory Standards Institute; Oxa, oxacillin; Pen, penicillin; Ctn, cephalotin; Ery, erythromycin; Cli, clindamycin; Chl, chloramphenicol; Cst, colistin; Cvf, cefovecin; Amp, ampicillin; Amc, amoxicillin/clavulanic acid; Tet, tetracycline; Enr, enrofloxacin; Orb, orbifloxacin; Dif, difloxacin; Kan, kanamycin; Sxt, trimethoprim/sulfamethoxazole; Gen, gentamicin; Ipm, imipenem; Amk, amikacin; R, resistant; I, intermediate; S, susceptible.
